Covestor LTD Instil Bio, Inc. Transaction History

Covestor LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.4 - $0.63 $4 - $7	-12 Reduced 12.0%	88 $0
Q2 2023 Aug 11, 2023	SELL	$0.51 - $0.67 $7 - $10	-15 Reduced 13.04%	100 $0
Q1 2023 May 15, 2023	BUY	$0.6 - $0.91 $57 - $86	95 Added 475.0%	115 $0
Q4 2022 Feb 13, 2023	SELL	$0.48 - $5.33 $0 - $10	-2 Reduced 9.09%	20 $0
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $18 - $29	-4 Reduced 15.38%	22 $0
Q2 2022 Aug 10, 2022	BUY	$4.21 - $11.15 $12 - $33	3 Added 13.04%	26 $0
Q1 2022 May 13, 2022	SELL	$8.48 - $18.1 $50 - $108	-6 Reduced 20.69%	23 $0
Q4 2021 Feb 10, 2022	BUY	$15.37 - $22.5 $445 - $652	29 New	29 $0

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

Stay updated on Covestor LTD with notifications on news.